Evidence map›Paper›PMID 31614459›Full record

ArticleNutrients2019

Anti-VEGF Signalling Mechanism in HUVECs by Melatonin, Serotonin, Hydroxytyrosol and Other Bioactive Compounds.

Ana B Cerezo, María Labrador, Andrés Gutiérrez, Ruth Hornedo-Ortega, Ana M Troncoso, M Carmen Garcia-Parrilla

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Mechanisms ofIntegrative cancer therapies
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Ana B CerezoDepartamento de Nutrición y Bromatología, Toxicología y Medicina Legal, Facultad de Farmacia, Universidad de Sevilla. C/Profesor García González 2, 41012 Sevilla, Spain. acerezo@us.es.ORCID 0000-0001-9290-2535
María LabradorDepartamento de Nutrición y Bromatología, Toxicología y Medicina Legal, Facultad de Farmacia, Universidad de Sevilla. C/Profesor García González 2, 41012 Sevilla, Spain. maria-labgra@hotmail.com.
Andrés GutiérrezDepartamento de Nutrición y Bromatología, Toxicología y Medicina Legal, Facultad de Farmacia, Universidad de Sevilla. C/Profesor García González 2, 41012 Sevilla, Spain. andgutlor@gmail.com.
Ruth Hornedo-OrtegaMIB, Unité de Recherche Œnologie, EA4577, USC 1366 INRA, ISVV, Université de Bordeaux, 33822 Villenave d'Ornon, Cedex, France. rhornedo@us.es.ORCID 0000-0003-1898-8806
Ana M TroncosoDepartamento de Nutrición y Bromatología, Toxicología y Medicina Legal, Facultad de Farmacia, Universidad de Sevilla. C/Profesor García González 2, 41012 Sevilla, Spain. amtroncoso@us.es.ORCID 0000-0003-0291-2823
M Carmen Garcia-ParrillaDepartamento de Nutrición y Bromatología, Toxicología y Medicina Legal, Facultad de Farmacia, Universidad de Sevilla. C/Profesor García González 2, 41012 Sevilla, Spain. mcparrilla@us.es.ORCID 0000-0002-0436-2784
Universidad de Sevilla · ESUniversité de Bordeaux · FR

Funding

Ministerio de Economía y Competitividad AGL2016-77505-C3-2-R
6 · The paper itself

Abstract

Angiogenesis drives evolution and destabilisation of atherosclerotic plaques and the growth and expansion of tumour cells. Vascular endothelial growth factor (VEGF) is the main endogenous pro-angiogenic factor in humans. The aim was to provide insight into the anti-VEGF activity of bioactive compounds derived from aromatic amino acids (serotonin, melatonin, 3-indoleacetic acid, 5-hydroxytryptophol and hydroxytyrosol). Experiments involved endothelial cell migration (wound-healing assay), the molecular mechanisms (ELISA assay) and the downstream effects (phospholipase C gamma 1 (PLCγ1), protein kinase B (Akt) and endothelial nitric oxide synthase (eNOS) by Western blot) on human umbilical vein endothelial cells (HUVECs). The data suggest for the first time that hydroxytyrosol interacts with surface components of the endothelial cell membrane (, preventing VEGF from activating its receptor. Serotonin and 5-hydroxytryptophol significantly inhibited HUVEC migration (98% and 50%, respectively) following the same mechanism. Conversely to other bioactive compounds, the anti-angiogenic effect of melatonin, serotonin, 3-indoleacetic acid and 5-hydroxytryptophol is not mediated via PLCγ1. However, hydroxytyrosol inhibits PLCγ1 phosphorylation. Additionally, melatonin and serotonin maintained eNOS phosphorylation and hydroxytyrosol significantly activated eNOS-all via Akt. These data provide new evidence supporting the interest in melatonin, serotonin, 3-indoleacetic acid, 5-hydroxytryptophol and hydroxytyrosol for their further exploitation as anti-VEGF ingredients in food.

Indexed as

Gene Expression RegulationHumansHuman Umbilical Vein Endothelial CellsHydroxytryptopholIndoleacetic AcidsMelatoninNeovascularization, PhysiologicNitric Oxide Synthase Type IIIPhenylethyl AlcoholPhospholipase C gammaProto-Oncogene Proteins c-aktSerotoninSignal TransductionVascular Endothelial Growth Factor A3,4-dihydroxyphenylethanolHydroxytryptopholindoleacetic acidIndoleacetic AcidsMelatoninNitric Oxide Synthase Type IIIPhenylethyl AlcoholPhospholipase C gammaPLCG1 protein, humanProto-Oncogene Proteins c-aktSerotoninVascular Endothelial Growth Factor A3-indoleacetic acid5-hydroxytryptopholAktangiogenesiseNOShydroxytyrosolmelatoninPLCγ1serotoninVEGF

Identifiers

PMID31614459
PMCPMC6836248
OpenAlexW2980090740

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.